<DOC>
	<DOC>NCT00598104</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of QAX576 against asthma attacks in adults with moderate persistent allergic asthma</brief_summary>
	<brief_title>Safety and Efficacy of QAX576 in Adults With Moderate Persistent Allergic Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>History of asthma attacks Taking inhaled corticosteroids Nonsmoking Women of childbearing potential History of respiratory disease other than asthma History of severe allergy to food or drugs Previous use of monoclonal antibodies Very low or high body weight Other protocoldefined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Asthma, interleukin-13</keyword>
</DOC>